Hao Wang

机构：Henan Cancer Hospital · ORCID：0009-0004-1597-8164

发表论文 51 篇 · 总被引 1084 次 · h-index 15

代表论文

• Microbes in lung cancer initiation, treatment, and outcome: Boon or bane? (2021 · Seminars in Cancer Biology · 被引 49)
• FOXP3-based immune risk model for recurrence prediction in small-cell lung cancer at stages I–III (2021 · Journal for ImmunoTherapy of Cancer · 被引 29)
• Co-Mutation of FAT3 and LRP1B in Lung Adenocarcinoma Defines a Unique Subset Correlated With the Efficacy of Immunotherapy (2022 · Frontiers in Immunology · 被引 27)
• Recent Progress in CDK4/6 Inhibitors and PROTACs (2023 · Molecules · 被引 25)
• Human leukocyte antigen class II-based immune risk model for recurrence evaluation in stage I–III small cell lung cancer (2021 · Journal for ImmunoTherapy of Cancer · 被引 25)
• Mechanisms of Progression and Heterogeneity in Multiple Nodules of Lung Adenocarcinoma (2021 · Small Methods · 被引 18)